Home NDC 63323-812 Oxacillin
Product NDC 63323-812
11-digit product format 633230812
Labeler code 63323
Product ID 63323-812_c7907a70-1efa-46eb-b046-fcf043fdb413
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Oxacillin
Dosage form INJECTION, POWDER, FOR SOLUTION
Route INTRAMUSCULAR; INTRAVENOUS
Labeler Fresenius Kabi USA, LLC
Application ANDA206198
Marketing category ANDA
Marketing start 2020-11-01
Substance OXACILLIN SODIUM
Active strength 2 g/20mL
Pharmacologic classes Penicillin-class Antibacterial [EPC], Penicillins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A206198-001 OXACILLIN SODIUM OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 A206198-002 OXACILLIN SODIUM OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 74 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP RS 2020-07-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 782e0a99824c…2021-12-28 21:50 UTC 2021-12 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A206198-001 OXACILLIN SODIUM EQ 1GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A206198-002 OXACILLIN SODIUM EQ 2GM BASE/VIAL INJECTABLE / INJECTION AP 2020-07-20 87673890dc5c…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 74 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Oxacillin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength OXACILLIN SODIUM 2 g/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination G0V6C994Q5 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1743547 Internal RxNorm lookup 1743549 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 63323-812-01 Oxacillin 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, FOR SOLUTION 20 3 63323-812-20 Oxacillin 10 in 1 CARTON INJECTION, POWDER, FOR SOLUTION 10 3
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 63323-812 OXACILLIN INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] 3 Current NDC, Legacy NDC, 2 package rows 20201101_af2dccac-98c8-488f-a133-6374b3ca8dba.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 63323-812-01 63323081201 20 mL in 1 VIAL, SINGLE-DOSE 20 ml Historical 63323-812-20 63323081220 10 VIAL, SINGLE-DOSE in 1 CARTON (63323-812-20) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-812-01) 2020-11-01 0000-00-00 No No Current